Search
Now showing items 11-20 of 20
Catabolite repression control (crc) gene and pseudomonas virulence
(2002-08-22)
A method of screening for compounds that inhibit the virulence of Pseudomonas bacteria comprises the steps of: providing a culture medium comprising Pseudomonas bacteria; administering a test compound to said bacteria; and ...
Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
(2002-10-17)
A method of reducing organ toxicity in a subject being administered a cytotoxic agent comprising concurrently administering with the cytotoxic agent erythropoietin (EPO), the EPO being administered in an amount effective ...
Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
(2002-10-31)
A composition comprises as the active agent a Non-glucocorticoid steroid, analogue thereof, a ubiquinone, or their salts, in an amount effective for reducing levels of, or hypersensitivity to, adenosine, increasing levels ...
Systems, methods and computer program products for creating and maintaining electronic medical records
(2002-07-04)
Systems, methods, and computer program products that generate electronic clinical medical records from patient encounters are provided. An illness for a particular patient is entered into a data processing system via an ...
Method and apparatus for treating renal disease with hemodialysis utilizing pulsatile pump
(2002-08-22)
A method of removing toxins from blood from a patient in need of such toxin removal includes: providing a countercurrent dialysis filter (20) having a blood compartment and a dialysate compartment separated from the blood ...
Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
(2002-08-13)
A composition, device, kit and method for countering or diagnosing cytidine deaminase or deoxycytidine deaminase over-expression or a disorder associated with it, or an increase in number or toxicity of pro-inflammatory ...
Satiety inducing composition comprising Neuropeptide Y analogues and methods of inducing satiety and treating a disease or condition associated with it
(2002-07-30)
Satiety inducing composition comprises Neuropeptide Y analogues which are effective for inducing satiety and for treating diseases and conditions associated with a lacking of, or having lowered, satiety.
The agony of agonal respiration: is the last gasp necessary?
(East Carolina University, 2002-06)
Gasping respiration in the dying patient is the last respiratory pattern prior to terminal apnoea. The
duration of the gasping respiration phase varies; it may be as brief as one or two breaths to a
prolonged period of ...
Dying in the city of the blues: sickle cell anemia and the politics of race and health
(East Carolina University, 2002-10)